A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD

This pilot study is a randomized, double-blind, sham-controlled study designed to evaluate
the efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in college students with
ADHD. A total of 40 subjects will be treated.

Twenty (20) subjects will receive active treatment with MeRT and the other 20 with sham.
Subjects in each study group will be treated 30 min a day, 5 days a week for 4 weeks. This is
known as Phase 1. During this study period, subjects and clinicians will be blind to
treatment condition.

Subjects will be recruited from a flyer describing the study. The flyer will be posted at the
Kortschak Center for Learning and Creativity, the McKay Center, and through Student
Counseling Services in the Engemann Student Health Center. In addition, students who have
been diagnosed with ADHD and have been seen at one of these facilities for ADHD may be
provided contact information for the study.

Inclusion Criteria:

Subjects must meet all of the following inclusion criteria to qualify for enrollment into
the study:

1. College student 18-25 years of age

2. Diagnosed with ADHD using the standardized clinical interview and supported by the
Pearson Quotient ADHD System and Conners Adult ADHD Rating Scales (CAARS)

3. Willing and able to adhere to the treatment schedule and all required study visits

Exclusion Criteria:

Subjects will be excluded from study participation if one of the following exclusion
criteria applies:

1. Pregnant or trying to become pregnant; negative urine pregnancy test at screening will
be required of females of child-bearing potential

2. Any antipsychotic or anticonvulsant medication.

3. Any type of rTMS treatment within 3 months prior to the screening visit

4. Intracranial implant (e.g., aneurysm clips, shunts, stimulators, cochlear implants,
stents, or electrodes) or any other metal object within or near the head, excluding
the mouth, which cannot be safely removed

5. Any condition which in the judgment of the investigator would prevent the subject from
completing the study

6. Any seizure history within the past 10 years

7. EEG abnormalities including indications of risk of seizure, i.e., abnormal focal or
general slowing in spikes during the EEG recording

8. Unstable medical conditions such as uncontrolled endocrine, hepatic, cardiac,
pulmonary and/or renal disorders.